RPCEC00000171已完成4 期
Effects of the administration of Abexol (D-002) and Prevenox (D-003) in subjects with osteoarthritis symptoms
Center of Natural Product / National Center for Scientific Research0 个研究点目标入组 120 人开始时间: 2013年9月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 20 years 至 80 years（—）
- 性别
- All
入选标准
- •The sample will be made ??up of:
- •1. Women and men.
- •2. Ages between 20 and 80 years.
- •3. With symptoms of OA (joint pain in hip, spine, limbs and / or phalanges).
- •4. Which have agreed to give informed consent.
- •5. Patients classified in Scales I-III of the American Association of Rheumatology.
- •6. Patients with WOMAC score = 25.
排除标准
- •1. Existence of other forms of arthritis.
- •2. Arthroplasty in the last 3 years.
- •3. Any orthopedic surgery in the last 3 years.
- •4. Transplanted.
- •5. Active liver or kidney diseases.
- •6. Neoplasms diagnosed.
- •7. Severe high blood pressure
- •8. Uncompensated diabetes mellitus (fasting glucose> 7 mmol / L).
- •9. Hospitalization for any cause in the previous 6 months.
- •11. Subjects with normal clinical history of allergy to any other medicines
- •12. Subjects with other special conditions that endanger their health and their lives during the study.
研究者
相似试验
尚未招募
4 期
Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months.Musculoskeletal DiseasesRheumatic DiseasesJoint DiseasesArthritisOsteoarthritisRPCEC00000222Center of Natural Products, National Center for Scientific Research60
尚未招募
4 期
Abexol and Atorvastatin in the non alcoholic steatohepatitison-Alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver DiseaseLiver DiseasesDigestive System DiseasesFatty LiverRPCEC00000221Center of Natural Products, National Center for Scientific Research100
尚未招募
4 期
D002/Lyprinol for osteoarthritisOsteoarthritis symptomsRPCEC00000166Center of Natural Products, National Center for Scientific Research50
进行中（未招募）
1 期
Evaluation of thesafety and efficacy of ambroxol in Gaucher disease caused by carrying the c.1448T>C mutation (p.Leu483Pro) and other rare variants of the GBA gene, based on clinical evaluation and results of genetic and metabolomic analysesGaucher diseaseEUCTR2021-006224-40-PLInstytut ,,Pomnik-Centrum Zdrowia Dziecka40
进行中（未招募）
1 期
clinical research study to find out if buparlisib (BKM120) in combination with docetaxel therapy is safe and has beneficial effects in people who have advanced or metastatic squamous non-small cell lung cancer and were previously treated with platinum-based chemotherapy.EUCTR2013-000833-11-GBovartis Pharma Services AG211